These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8341311)

  • 41. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.
    Volkow ND; Fowler JS; Wang GJ; Hitzemann R; Logan J; Schlyer DJ; Dewey SL; Wolf AP
    Synapse; 1993 Jun; 14(2):169-77. PubMed ID: 8101394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease.
    Rinne UK; Laihinen A; Rinne JO; Någren K; Bergman J; Ruotsalainen U
    Mov Disord; 1990; 5(1):55-9. PubMed ID: 2136932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Late onset hemiparkinsonism-hemiatrophy syndrome: a case report].
    Fukae J; Mochizuki H; Ohashi R; Mitani K; Kawada J; Mizuno Y
    Rinsho Shinkeigaku; 2005 May; 45(5):390-3. PubMed ID: 15960180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
    Smith Y; Villalba R
    Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET.
    Shinotoh H; Hirayama K; Tateno Y
    Adv Neurol; 1993; 60():488-93. PubMed ID: 8420176
    [No Abstract]   [Full Text] [Related]  

  • 46. Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits.
    Holthoff VA; Vieregge P; Kessler J; Pietrzyk U; Herholz K; Bönner J; Wagner R; Wienhard K; Pawlik G; Heiss WD
    Ann Neurol; 1994 Aug; 36(2):176-82. PubMed ID: 8053653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case report.
    Ishibashi K; Nishina H; Ishiwata K; Ishii K
    BMC Res Notes; 2015 Sep; 8():496. PubMed ID: 26419749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine receptors in Parkinson's disease.
    Guttman M
    Neurol Clin; 1992 May; 10(2):377-86. PubMed ID: 1584180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversible striatal hypermetabolism in a case of Sydenham's chorea.
    Goldman S; Amrom D; Szliwowski HB; Detemmerman D; Goldman S; Bidaut LM; Stanus E; Luxen A
    Mov Disord; 1993 Jul; 8(3):355-8. PubMed ID: 8341301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positron emission tomography studies in parkinsonism.
    Eidelberg D
    Neurol Clin; 1992 May; 10(2):421-33. PubMed ID: 1584183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neurotransmitter systems in the human brain studied by positron emission tomography].
    Shinotoh H
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1313-5. PubMed ID: 9128390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].
    Li TL; Xu JF; Wang J; Zhang H; Mao SY; Wen SQ; Zhou Y
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(29):2068-72. PubMed ID: 22093938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
    Lang AE
    Mov Disord; 1995 Jul; 10(4):489-95. PubMed ID: 7565831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathophysiology of movement disorders studied using PET.
    Leenders KL
    J Neural Transm Suppl; 1997; 50():39-46. PubMed ID: 9120423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Study on dopamine D2 binding capacity in vascular parkinsonism].
    Terashi H; Nagata K; Hirata Y; Hatazawa J; Utsumi H
    Rinsho Shinkeigaku; 2001 Oct; 41(10):659-64. PubMed ID: 11993184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The detection of preclinical Parkinson's disease: what is the role of positron emission tomography?
    Sawle GV
    Mov Disord; 1993 Jul; 8(3):271-7. PubMed ID: 8341290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Striatal glucose metabolism and [18F]fluorodopa uptake in a patient with tumor-induced hemiparkinsonism.
    Miyagi Y; Morioka T; Otsuka M; Fukui M
    Neurosurgery; 1993 May; 32(5):838-41. PubMed ID: 8492861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral glucose metabolism in Parkinson's disease.
    Martin WR; Beckman JH; Calne DB; Adam MJ; Harrop R; Rogers JG; Ruth TJ; Sayre CI; Pate BD
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):169-73. PubMed ID: 6608981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Positron emission tomography and basal ganglia functions].
    Kato M
    No To Shinkei; 1990 May; 42(5):450-60. PubMed ID: 2206633
    [No Abstract]   [Full Text] [Related]  

  • 60. Uptake of 77Br-spiperone in the striata of schizophrenic patients and controls.
    Crawley JC; Crow TJ; Johnstone EC; Oldland SR; Owen F; Owens DG; Smith T; Veall N; Zanelli GD
    Nucl Med Commun; 1986 Aug; 7(8):599-607. PubMed ID: 2946010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.